Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?

Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?

The benefit of adjuvant immunotherapy after nephrectomy in renal cell carcinoma (RCC) is controversial. The present study aimed to examine the possible benefit of adjuvant immunotherapy in various clinical settings.We retrospectively reviewed 436 patients with pT1-3N0-2M0 RCC who underwent radical o...

Full description

Bibliographic Details
Main Authors: Satoru Taguchi, Sebastiano Buti, Hiroshi Fukuhara, Masafumi Otsuka, Melissa Bersanelli, Teppei Morikawa, Hideyo Miyazaki, Tohru Nakagawa, Tetsuya Fujimura, Haruki Kume, Yasuhiko Igawa, Yukio Homma
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5328261?pdf=render

Internet

http://europepmc.org/articles/PMC5328261?pdf=render

Similar Items